PT1658081E - Immunosuppressive effects of pteridine derivatives - Google Patents

Immunosuppressive effects of pteridine derivatives Download PDF

Info

Publication number
PT1658081E
PT1658081E PT04761485T PT04761485T PT1658081E PT 1658081 E PT1658081 E PT 1658081E PT 04761485 T PT04761485 T PT 04761485T PT 04761485 T PT04761485 T PT 04761485T PT 1658081 E PT1658081 E PT 1658081E
Authority
PT
Portugal
Prior art keywords
immunosuppressive effects
pteridine derivatives
pteridine
derivatives
immunosuppressive
Prior art date
Application number
PT04761485T
Other languages
Portuguese (pt)
Inventor
Mark Jozef Albert Waer
Arnaud Didier Marie Marchand
Piet Andre Maurits Maria Herdewijn
Wolfgang Eugen Pfleiderer
Steven Cesar Alfons De Jonghe
Original Assignee
4 Aza Ip Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/651,604 external-priority patent/US7276506B2/en
Application filed by 4 Aza Ip Nv filed Critical 4 Aza Ip Nv
Publication of PT1658081E publication Critical patent/PT1658081E/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/34Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/40Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
PT04761485T 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives PT1658081E (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/651,604 US7276506B2 (en) 1998-12-28 2003-08-29 Immunosuppressive effects of pteridine derivatives
GB0408955A GB2413324A (en) 2004-04-22 2004-04-22 Pharmaceutically active pteridine derivatives

Publications (1)

Publication Number Publication Date
PT1658081E true PT1658081E (en) 2008-01-15

Family

ID=32344196

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04761485T PT1658081E (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives

Country Status (3)

Country Link
JP (1) JP2007533610A (en)
GB (1) GB2413324A (en)
PT (1) PT1658081E (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012262014B2 (en) * 2011-06-01 2016-07-14 Janus Biotherapeutics, Inc. Novel immune system modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356380C (en) * 1998-12-28 2008-06-17 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
SE0003828D0 (en) * 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
GB2413324A (en) 2005-10-26
JP2007533610A (en) 2007-11-22
GB0408955D0 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
IL189658A0 (en) N-phenyl-2-pyrimidine-amine derivatives
HK1091488A1 (en) Pyrimidine derivatives
HK1086257A1 (en) Diazepinoindole derivatives as kinase inhibitors
HK1088602A1 (en) 2-pyridinecarboxamide derivatives
HK1088326A1 (en) Piperidine-benzenesulfonamide derivatives
IL173380A0 (en) Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
GB0322409D0 (en) Quinazoline derivatives
HK1089443A1 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
IL176469A0 (en) Novel phenylalanine derivatives
TWI347187B (en) Pyrido-and pyrimidopyrimidine derivatives
GB0317665D0 (en) Qinazoline derivatives
PL1682493T3 (en) Amidoacetonitrile derivatives
GB0321648D0 (en) Quinazoline derivatives
IL174512A0 (en) Pyrazolo and imidazo-pyrimidine derivatives
IL172375A0 (en) Chinazoline derivatives as aurora kinase inhibitors
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
AU2003254051A8 (en) Pyrazolopyrimidines as kinase inhibitors
PT1706373E (en) Amidoacetonitrile derivatives
GB0329695D0 (en) Dynamic lighting
GB0319793D0 (en) Pyridinylmorpholine derivatives
PT1658081E (en) Immunosuppressive effects of pteridine derivatives
GB0321621D0 (en) Quinazoline derivatives
SI1658081T1 (en) Immunosuppressive effects of pteridine derivatives
GB0321620D0 (en) Quinazoline derivatives
GB0307377D0 (en) Ergoline derivatives